USPTO serial 90302923
EUROAPI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 23, 2021
- Examiner
- MARTIN, CHRISTINE C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with EUROAPI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Karen Lim
Karen Lim FROSS ZELNICK LEHRMAN & ZISSU, P.C.151 WEST 42ND STREET, 17TH FLOORNEW YORK, NY 10036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry and science | ACTIVE | — |
| 005 | Pharmaceutical preparations for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, respiratory diseases, cancer, allergies, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, eye disease, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; hormones; vitamins; dietetic foods adapted for medical use; bacterial preparations for medical and veterinary use; disinfectants for hygienic purposes; medicated supplements for foodstuffs for medical or veterinary use; dietetic foods and beverages adapted for veterinary and medical use; food supplements for human beings and animals; disinfectants; biochemicals, namely, monoclonal antibodies for pharmaceutical use | ACTIVE | — |
| 040 | Treatment of chemicals, namely, custom manufacture and custom synthesis of pharmaceuticals and active pharmaceutical ingredients; Technical and scientific services, namely, providing technical information in the field of pharmaceutical manufacturing | ACTIVE | — |
| 042 | Research and development services in the field of health and biotechnologies, namely, research in the area of the development of new active elements; research in the area of a means of synthesis in the field of pharmaceutical products; scientific study and research in the area of industrial quality; development of methods of analysis for chemical and pharmaceutical products and bioorganics; development and studies of analytical methods checking chemical reactions; Scientific and technological services, namely, consulting and assistance in the research and development of pharmaceuticals; scientific and technical services, namely, scientific analysis of industrial installations; scientific research and development services in the field of pharmaceuticals; scientific research and development services for chemicals for the products of third parties, namely, the scientific and technical development of synthetic processes in the field of chemistry and biochemistry; scientific research and scientific and technical development in the field of pharmaceutical, chemical, agrochemical and industrial processes; scientific services, namely, scientific research and industrial analysis in the field of pharmaceuticals, chemicals, and agrochemical and industrial processes; scientific services, namely, scientific analysis allowing the identification and physical characterization of chemical molecules; scientific and technological services, namely, applied scientific research and development services, namely, conception of development or commercial batches for third parties in the fields of pharmaceuticals and chemicals; formulation and pre-formulation process design for pharmaceutical, chemical or agrochemical products; engineering services, namely, formulation, process evaluation and project management in the scientific and industrial fields, mainly in the chemical and pharmaceutical fields; engineering services for chemical and organic products and the processing thereof in the field of basic and industrial technology; scientific and technological services, namely, consulting and assistance in the research and development of chemicals and pharmaceuticals, including experimental and production processes and installations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by EUROAPI
- Other trademarks owned by Sanofi
- Other trademarks owned by Sanofi
- Other trademarks owned by Sanofi
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named EUROAPI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 29, 2022 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Nov 23, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 7, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 7, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 18, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 4, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 29, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 29, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 29, 2021 | ALIE | ASSIGNED TO LIE | — |
| Jul 26, 2021 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Feb 16, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 16, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 16, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 11, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 11, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 11, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 21, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 21, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 21, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 20, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 6, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 10, 2020 | NWAP | NEW APPLICATION ENTERED | — |